Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added; references to Melanoma, MedlinePlus Genetics, and Revision: v3.4.2 were removed. These appear to be administrative updates that do not change the study details or user interactions on the page.
    Difference
    0.1%
    Check dated 2026-03-07T14:52:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added Melanoma as a topic and included MedlinePlus Genetics as related topics.
    Difference
    0.1%
    Check dated 2026-02-28T11:59:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added the 2026 NEJM article 'Nivolumab for Resected Stage III or IV Melanoma at 9 Years' to Publications and removed the 2025 ahead-of-print citation.
    Difference
    0.0%
    Check dated 2026-02-21T05:56:29.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; this appears to be a minor version update with no visible changes to page content or user-facing features.
    Difference
    0.0%
    Check dated 2026-02-14T05:13:11.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-02-07T04:59:09.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added related topic references for Melanoma and MedlinePlus Genetics on the page. These links appear as auxiliary educational references and do not change the study details or user actions.
    Difference
    0.1%
    Check dated 2026-01-31T02:01:16.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.